Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 5 (2008), Issue 7 (July)

1. Schwannoma of the intermediate nerve.
   J Neurosurg, 109(1): 144-8. [Abstract] [Full-text]
2. Metachronous mature teratoma in the corpus callosum occurring 12 years after a pineal germinoma.
   J Neurosurg, 109(1): 126-9. [Abstract] [Full-text]
3. Identification of a human leukocyte antigen-A24-restricted T-cell epitope derived from interleukin-13 receptor alpha2 chain, a glioma-associated antigen.
   J Neurosurg, 109(1): 117-22. [Abstract] [Full-text]
4. Effect of ropivacaine skull block on perioperative outcomes in patients with supratentorial brain tumors and comparison with remifentanil: a pilot study.
   J Neurosurg, 109(1): 44-9. [Abstract] [Full-text]
5. Thyroid-stimulating hormone pituitary adenomas.
   J Neurosurg, 109(1): 17-22. [Abstract] [Full-text]
6. Outcomes following endoscopic, expanded endonasal resection of suprasellar craniopharyngiomas: a case series.
   J Neurosurg, 109(1): 6-16. [Abstract] [Full-text]
7. Extraventricular neurocytoma in neurofibromatosis Type 1: case report.
   J Neurosurg Pediatrics, 2(1): 63-7. [Abstract] [Full-text]
8. The asleep-awake technique using propofol-remifentanil anaesthesia for awake craniotomy for cerebral tumours.
   Eur J Anaesthesiol, 25(8): 662-9. [Abstract] [Full-text]
9. Endoscopic transnasal craniotomy and the resection of craniopharyngioma.
   Laryngoscope, 118(7): 1142-8. [Abstract] [Full-text]
10. Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression.
    Clin Cancer Res, 14(13): 4154-60. [Abstract] [Full-text]
11. Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis.
    Br J Cancer, 99(1): 160-6. [Abstract] [Full-text]
12. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.
    Am J Surg Pathol, 32(7): 1051-9. [Abstract] [Full-text]
13. Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.
    J Clin Oncol, 26(20): 3387-94. [Abstract] [Full-text]
14. FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities.
    Oncogene, 27(30): 4180-90. [Abstract] [Full-text]
15. Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas.
    Cancer Genet Cytogenet, 184(2): 77-86. [Abstract] [Full-text]
16. Modulation of CD59 expression by restrictive silencer factor-derived peptides in cancer immunotherapy for neuroblastoma.
    Cancer Res, 68(14): 5979-87. [Abstract] [Full-text]
17. Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients.
    Cancer Res, 68(14): 5955-64. [Abstract] [Full-text]
18. New insights into tumor microstructure using temporal diffusion spectroscopy.
    Cancer Res, 68(14): 5941-7. [Abstract] [Full-text]
19. Noninvasive assessment of E2F-1-mediated transcriptional regulation in vivo.
    Cancer Res, 68(14): 5932-40. [Abstract] [Full-text]
20. Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells.
    Cancer Res, 68(14): 5778-84. [Abstract] [Full-text]
21. Merlin is a potent inhibitor of glioma growth.
    Cancer Res, 68(14): 5733-42. [Abstract] [Full-text]
22. PAX8 regulates telomerase reverse transcriptase and telomerase RNA component in glioma.
    Cancer Res, 68(14): 5724-32. [Abstract] [Full-text]
23. Temozolomide preferentially depletes cancer stem cells in glioblastoma.
    Cancer Res, 68(14): 5706-15. [Abstract] [Full-text]
24. Presurgical functional MR imaging of language and motor functions: validation with intraoperative electrocortical mapping.
    Radiology, 248(2): 579-89. [Abstract] [Full-text]
25. Resveratrol and X rays affect gap junction intercellular communications in human glioblastoma cells.
    Mol Carcinog, 47(8): 587-98. [Abstract] [Full-text]
26. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
    Am J Surg Pathol, 32(8): 1220-7. [Abstract] [Full-text]

© 2004-2008 Brain Cancer Research Today. All Rights Reserved.